Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections

Dalbavancin is a lipoglycopeptide with potent activity against Gram-positive microorganisms, a long half-life, a favorable safety profile, and a high concentration in bone, which makes it an interesting alternative for treatment of osteoarticular infections. We performed a multicentric retrospective...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Morata, L., Cobo, J., Fernández-Sampedro, M., Guisado Vasco, P., Ruano, E., Lora-Tamayo, J., Sánchez Somolinos, M., González Ruano, P., Rico Nieto, A., Arnaiz, A., Estébanez Muñoz, M., Jiménez-Mejías, M. E., Lozano Serrano, A. B., Múñez, E., Rodriguez-Pardo, D., Argelich, R., Arroyo, A., Barbero, J. M., Cuadra, F., Del Arco, A., del Toro, M. D., Guio, L., Jimenez-Beatty, D., Lois, N., Martin, O., Martínez Alvarez, R. M., Martinez-Marcos, F. J., Porras, L., Ramírez, M., Vergas García, J., Soriano, A.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2019
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496098/
https://ncbi.nlm.nih.gov/pubmed/30858217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02280-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars